Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, November 9, 2023
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
[ Thu, Nov 09th 2023
] - WOPRAI
Colin Langan Maintained (ADNT) at Buy with Decreased Target to $41 on, Nov 9th, 2023
Colin Langan of Wells Fargo, Maintained "Adient plc" (ADNT) at Buy with Decreased Target from $49 to $41 on, Nov 9th, 2023.
Colin has made no other calls on ADNT in the last 4 months.
There are 4 other peers that have a rating on ADNT. Out of the 4 peers that are also analyzing ADNT, 1 agrees with Colin's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Ryan Brinkman of "JP Morgan" Maintained at Hold with Increased Target to $42 on, Thursday, July 20th, 2023
These are the ratings of the 3 analyists that currently disagree with Colin
- Dan Levy of "Barclays" Maintained at Buy with Decreased Target to $52 on, Friday, October 13th, 2023
- Adam Jonas of "Morgan Stanley" Maintained at Sell with Increased Target to $38 on, Tuesday, August 8th, 2023
- Michael Ward of "Benchmark" Maintained at Strong Buy with Increased Target to $62 on, Monday, August 7th, 2023
